Arcturus Therapeutics Holdings Inc. ARCT
Set alert
9.23 USD -0.27 -2.79%
As of Nov 3, 1:57 PM ET
9.21 Day range 10.03
5.50 52-week range 17.96
- YTD
- +50.49%
- 1 year
- -0.81%
- Open
- 9.55
- Prev close
- 9.49
- Mkt cap
- 262.49M
- Vol
- 493.03K
- Avg vol
- 1.00M
- EPS
- -3.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.21
- High
- 10.03
- Forward P/E
- -7.41
- Beta
- 2.64
- Short ratio
- 9.41
- Inst. own
- 90.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 18.22
- 200-d avg
- 24.44
- 1y target
- 79.47
5Y chart
Events in this range
- Aug 7, 2023Earnings: -1.98; estimate 0.09; surprise -2300%
- Nov 14, 2023Earnings: -0.61; estimate -1.79; surprise 65.92%
- Mar 7, 2024Earnings: -0.32; estimate -1.69; surprise 81.07%
- May 8, 2024Earnings: -1; estimate -1.17; surprise 14.53%
- Aug 5, 2024Earnings: -0.64; estimate -1.85; surprise 65.41%
- Aug 6, 2024Rating: Cantor Fitzgerald · — → Overweight
- Aug 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 12, 2024Rating: Leerink Partners · — → Outperform
- Nov 7, 2024Earnings: -0.26; estimate -0.7; surprise 62.86%
- Nov 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 16, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Dec 17, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (96)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| RSI: Overbought | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Oct 20, 2025 | 1 year ago |
Newest 20 of 96.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 79.47 +761.4% upside
Now 9.23
- Target (low)
- 44.00
- Target (mean)
- 79.47
- Target (high)
- 140.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy3
- Buy7
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.22333 | -0.40 – 0.59 | -0.32 | +169.8% | 45.92M | +35.1% | 8 |
| Next quarter | -0.2725 | -0.69 – 0.00 | -1.00 | +72.8% | 53.00M | +39.4% | 4 |
| Current year | -1.92 | -2.30 – -1.29 | 0.2765 | -794.4% | 175.51M | +3.3% | 8 |
| Next year | -1.48 | -5.15 – 3.12 | -1.92 | +22.8% | 213.90M | +21.9% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 16, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Leerink Partners | Initiated | — | Outperform |
| Aug 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 6, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jul 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 11, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 8, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 8, 2024 | Citigroup | Maintained | Buy | Buy |
| Dec 13, 2023 | Canaccord Genuity | Initiated | — | Buy |
| Nov 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 24, 2023 | William Blair | Initiated | — | Outperform |
| Jul 14, 2023 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 14, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 11, 2023 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Mar 29, 2023 | Guggenheim | Reiterated | — | Buy |
| Mar 29, 2023 | HC Wainwright & Co. | Reiterated | — | Neutral |